Filter
611
Filtered Results: 611
Text search:
molecular
markers
Featured
Recommendations
75
New Publications
128
Language
Document type
No document type
274
Guidelines
123
Studies & Reports
122
Manuals
42
Strategic & Response Plan
23
Training Material
10
Fact sheets
10
Situation Updates
5
Resource Platforms
1
Online Courses
1
Countries / Regions
India
52
Global
25
Kenya
15
Latin America and the Carribbean
15
Tanzania
15
Africa
14
Western and Central Europe
12
Ethiopia
10
Nigeria
8
South Africa
8
Eastern Europe
8
South–East Asia Region
6
Uganda
6
Sierra Leone
5
Zimbabwe
5
Philippines
5
West and Central Africa
5
East and Southern Africa
5
Ukraine
4
Malawi
4
Asia
4
Western Pacific Region
4
Indonesia
4
Nepal
3
Cameroon
3
Congo, Democratic Republic of
3
Brazil
3
Myanmar / Burma
3
Pakistan
3
Ghana
2
Benin
2
Syria
2
Burkina Faso
2
Guinea
2
USA
2
Venezuela
2
Middle East and North Africa
2
North America
2
Bangladesh
2
Zambia
2
Liberia
2
North Macedonia
1
Timor Leste/ East Timor
1
Thailand
1
Lesotho
1
China
1
Rwanda
1
Senegal
1
Afghanistan
1
Peru
1
Malaysia
1
Cambodia
1
Jordan
1
Germany
1
Eastern Europe and Central Asia
1
Gabon
1
Japan
1
United Kingdom
1
Spain
1
Côte d’Ivoire / Ivory Coast
1
Lebanon
1
Vietnam
1
Namibia
1
Georgia
1
Angola
1
Chad
1
Somalia
1
Eswatini/ Swaziland
1
Authors & Publishers
Publication Years
Category
Countries
169
Clinical Guidelines
102
Public Health
41
Pharmacy & Technologies
26
Women & Child Health
16
Key Resources
15
Capacity Building
5
Toolboxes
TB
78
AMR
63
COVID-19
60
HIV
39
NTDs
34
Rapid Response
31
Mental Health
30
Planetary Health
23
NCDs
17
Ebola
14
Pharmacy
13
Refugee
8
Specific Hazards
6
Global Health Education
6
Zika
5
Polio
5
Caregiver
4
Conflict
4
Disability
3
Cholera
3
Natural Hazards
2
Health Financing Toolbox
2
Social Ethics
1
Prepared as an outcome of ICMR Subcommittee on Breast Cancer |.This consensus document on management of breast cancers summarizes the
modalities of treatment including the site-specific anti-cancer therapies, supportive and palliative care and molecular markers and research questions. It also inter...
Prepared as an outcome of ICMR Subcommittee on Buccal Mucosa Cancer | This consensus document on management of Buccal Mucosa cancers summarizes the modalities of treatment including the site-specific anti-cancer therapies, supportive and palliative care and molecular markers and research questions. ...
Prepared as an outcome of ICMR Subcommittee on Cancer Cervix | This consensus document on management of cervix cancer summarizes the modalities of treatment including the site-specific anti-cancer therapies, supportive and palliative care and molecular markers and research questions. It also interwe...
Prepared as an outcome of ICMR Subcommittee on Colorectal Cancer | Coordinated by Division of Non Communicable Diseases | This Consensus Document on Management of Colorectal Cancer summarizes the modalities of treatment including the site-specific anti-cancer therapies,
supportive and palliative ca...
Prepared as an outcome of ICMR Subcommittee on Esophageal Cancer | This consensus document on management of esophageal cancers
summarizes the modalities of treatment including the site-specific anti-cancer therapies, supportive and palliative care and molecular markers and research questions. It a...
Prepared as an outcome of ICMR Subcommittee on Gastric Cancer | This consensus document on Management of Gallbladder cancers summarizes the modalities of treatment including the site-specific anti-cancer therapies, supportive and palliative care and molecular markers and research questions. It also ...
Prepared as an outcome of ICMR Subcommittee on Larynx & Hypopharynx Cancers | This consensus document on management of larynx and hypopharynx cancers summarizes the modalities of treatment including the site-specific anti-cancer therapies, supportive and palliative care and molecular markers and re...
Prepared as an outcome of ICMR Subcommittee on Multiple Myeloma | This consensus document on management of multiple myeloma summarizes the modalities of treatment including the site-specific anti-cancer therapies, supportive and palliative care and molecular markers and research questions. It also i...
Prepared as an outcome of ICMR Subcommittee on Non Hodgkin’s Lymphoma (High Grade) | This consensus document on management of non- hodgkin’s lymphoma – high grade summarizes the modalities of treatment including the site-specific anti-cancer therapies, supportive and palliative care and molec...
Prepared as an outcome of ICMR Subcommittee on Soft Tissue Sarcoma and Osteosarcoma | This consensus document on Management of Soft Tissue Sarcoma and Osteosarcoma summarizes the modalities of treatment including the site-specific anti-cancer therapies, supportive and palliative care and molecular ...
Prepared as an outcome of ICMR Subcommittee on Tongue Cancer | This Consensus Document on Management of Tongue Cancers summarizes the modalities of treatment including the site-specific anti-cancer therapies, supportive and palliative care and molecular markers and research questions. It also interw...
Full document available: https://www.icmr.nic.in/sites/default/files/guidelines/Gastric%20Cancer%20Final%20pdf%20for%20farrow_0.pdf | Prepared as an outcome of ICMR Subcommittee on Gastric Cancer | Coordinated by Division of Non Communicable Diseases | This Consensus Document on Management of Gastri...
Discrete typing units of Trypanosoma cruzi: Geographical and biological distribution in the Americas
Chagas disease caused by Trypanosoma cruzi is a public health issue in Latin America. This highly diverse parasite is divided into at least seven discrete typing units (DTUs) TcI-TcVI and Tcbat. Some DTUs have been associated with geographical distribution in epidemiological scenarios and clinical m...
Pathogens . 2021 Nov 16;10(11):1493.doi: 10.3390/pathogens10111493
.Chronic manifestations of Chagas disease present as disabling and life-threatening condi-tions affecting mainly the cardiovascular and gastrointestinal systems. Although meaningful research has outlined the different molecular mech...
Molecular methods for antimicrobial resistance (AMR)diagnostics to enhance the Global Antimicrobial Resistance Surveillance System
Annex to Selection and use of Ebola in vitro diagnostic assays
Expert opinion of the European Tuberculosis Laboratory Initiative core group members for the WHO European Region.
As a public good, antimicrobial medicines require rational use if their effectiveness is to be preserved. However, up to 50% of antibiotic use is inappropriate, adding considerable costs to patient care, and increasing morbidity and mortality. In addition, there is compelling evidence that antimicro...
Supplement to the Healthcare Waste Management Toolkit for Global Fund
Practitioners and Policy Makers
Antimalarial drug resistance has emerged as a threat to global malaria control efforts, particularly in the Greater Mekong subregion. Drawing on data collected through more than 1000 therapeutic efficacy studies as well as molecular marker studies of Plasmodium falciparum drug resistance, the Report...
